The European Commission has approved single-agent nivolumab for use in the adjuvant treatment of adult and adolescent patients aged 12 years or older who have stage IIB or IIC melanoma and who have undergone complete resection.
Evogene s (EVGN) Biomica Opens Second Site to Advance Its Immuno-Oncology Drug Trials at Davidoff Center streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
REHOVOT, Israel, Aug. 15, 2023 /PRNewswire/ Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. , has. -Today at 07:01 am- MarketScreener